A novel cell immunoassay to measure survival of motor neurons protein in blood cells


BACKGROUND The motor neuron degenerative disease spinal muscular atrophy (SMA) is the leading genetic cause of infant mortality and is caused by mutations in the survival of motor neurons (SMN) gene that reduce the expression levels of the SMN protein. A major goal of current therapeutic approaches is to increase SMN levels in SMA patients. The purpose of… (More)


  • Presentations referencing similar topics